Not all individuals with CLL need therapy. Inspite of all latest developments, the iwCLL nonetheless recommends watchful observation for patients with asymptomatic illness.86 This advice relies on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Deep, targeted upcoming-generation sequencing has... https://haimv753pxd9.wikinewspaper.com/user